TGA
Undeclared substances
The TGA has issued a safety advisory regarding BFB Be Fast Block Capsules, Big Penis U.S.A tablets and Lanky Genuine Capsules All three products pose a serious health risk and should …
Shortages continue
New advice on medicines shortages provided by regulators as shipping delays add another case to the list The TGA today advised that Prenoxad 1 mg/mL solution for injection in a …
Shortages roll on
The TGA has provided updated advice on the shortages of Anginine and Lycinate, as well as Clomid Arrow Pharmaceuticals, the sponsor of Anginine and Lycinate tablets, has advised the TGA …
Fixing the schedule
Changes to diclofenac, fluticasone and cannabis schedules confirmed by TGA The TGA’s Advisory Committee on Medicines Scheduling has confirmed earlier decisions to alter the scheduling of a number of widely …
Next steps: Consultation on strong opioid use and misuse
The TGA has commenced reviews into pack sizes, indications and label warnings for S8 opioids In response to rising numbers of opioid prescriptions and levels of overdose reaching “record levels”, …
New ‘hard-line approach’ to meds shortages
The Senate has passed legislation which will require pharmaceutical companies to report shortages of important medicines as they occur Based on the new legislation, medicine companies will have to report …
Sildenafil to remain script only
A committee has ruled against Viagra going OTC, saying the pharmacy setting is not equipped to provide medical diagnosis for underlying conditions of ED The Advisory Committee on Medicines Scheduling …
Keeping it in pharmacy
Scheduling committee to decide on making some paracetamol products Pharmacist Only The TGA has requested that its scheduling committee examine whether a certain category of paracetamol medicine be upscheduled to …
EpiPen contenders on the horizon?
While Mylan’s EpiPen has dominated the epinephrine injection market for years, two new contenders are planning to launch versions… could these help relieve shortages? With no generic versions and few …
Voltaren 2% gel to become general sale item
The medicines scheduling committee has ruled against the PSA and Guild, deciding that diclofenac up to 2% will be removed from the Schedule 2 entry from 1 October Late last …
The need for speed
Is the push for faster regulatory approval of new drugs a benefit to patients or a safety risk? The increasing pressure from patients, pharmaceutical companies and sometimes, health professionals, eager …